Home Physical Sciences Synthesis and antioxidant activity of 2-methylthio-pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidines
Article Open Access

Synthesis and antioxidant activity of 2-methylthio-pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidines

  • Hatem A. Abuelizz , Hanan A.A. Taie , Mohamed Marzouk and Rashad Al-Salahi EMAIL logo
Published/Copyright: October 12, 2019

Abstract

A series of 2-methylthio-pyrido-triazolopyrimidines (1-17) were prepared by the reaction of dimethyl-N-cyanoimidodithiocarbonate with hydrazinopyridine carboxylic acid as starting reactants. Their chemical structures were affirmed with HREI-MS, IR and NMR analyses. The target compounds (1-17) were evaluated for their antioxidant activity using 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical scavenging, ferric reduction antioxidant power (FRAP) and reducing power capability (RPC). The results revealed that some pyrido-triazolopyrimidines showed good activity as antioxidant agents, in particular, compounds 12 and 15 were found to possess good antioxidant activity. Butylated hydroxyl toluene (BHT) was used as reference drug.

1 Introduction

Extensive research in the organic-medicinal chemistry field has led to the discovery of different classes of bioactive substances, most of them being nitrogen-containing heterocycles. Within the huge number of nitrogenous heterocyclic products, in particular those containing

quinazoline, triazole, triazine, benzoquinazoline and triazoloquinazoline platforms, have been broadly scouted, showing to be highly versatile motif during the identification of new worthy and selective bioactive compounds for medicinal purposes.

One of the most challenging proceedings in the medicinal chemistry range is to explore and elaborate more potent drugs with only slight toxic effects and completely reversible. Thus, it is essential to consider the physiochemical features in the design and development of new bioactive constituents as well as their mechanism of action. Hundreds of thousands of new heterocyclic organic compounds are synthesized per year around the globe; many of them are submitted to biological screening for determination of their activities. These random investigation processes have been misfit, but they have led to discovery of new lead compounds whose structures have been optimized and developed to produce clinical agents.

Triazolo-annelated quinazolines were found to be potent adenosine antagonists, herbicidal and fungicidal agents [1, 2, 3]. In addition, further chemical transformation of their inherent lactam groups and substituent types at positions 2 and 5 were offered access to a variety of derivatives that have shown antihistamine, antimicrobial, antiviral, antihypertensive, anti-inflammatory, antitumor and antioxidant activities [4, 5, 6, 7, 8, 9, 10, 11]. In light of the above-mentioned facts, we are interested in the conversion of triazolquinazoline moiety into a pyridotriazolopyrimidine scaffold. This scaffold has already been reported as a potent fungicidal and herbicidal agent [2,3] and incorporated in various substances that displayed interesting antimicrobial activity [12]. The emergence of various diseases resulting from oxidative stress such as diabetes, cancer, stroke, and cardiovascular dysfunctions, requires a permanent revaluation search and adjustment of adequate strategy to design and develop new bioactive substances to protect the human body against such diseases. In continuation of our on-going program research dealing with antioxidants, this research deals with the preparation and characterization of 2-methylthio-pyrido-triazolopyrimidines (1-17); thereafter, evaluating their antioxidant activity using different assays.

2 Experimental

2.1 Chemistry

Employing a Bruker AMX (500, 700 and 150 MHz), a JEOL the MStation JMS-700 and a Perkin Elmer FT-IR Spectrum BX and a STUART Melting point SMP 10 systems to measure NMR, HREI-MS, IR spectra and melting points, respectively. The measured melting points on open glass capillaries were uncorrected. The NMR samples were prepared in DMSO-d6 and d-values are given in ppm downfielded from TMS. DC Mikrokarten polygram SIL G/UV254 (Macherey-Nagel Firm, Duren Thickness: 0.25 mm) was used for following-up of the reactions and examining the purity of substances by TLC.

2.1.1 Preparation of 2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-5(4H)-one (1)

2-Hydrazinonicotinic acid (5.5 mmol) was mixed with a solution of dimethyl-N-cyanoimdiodithiocarbonate (5 mmol) in EtOH (20 mL) at RT. Thereafter, Et3N (20 mmol) was added gradually through for 10 min. After completion, the reaction mixture was stirred overnight at RT. Then, the reaction mixture was acidified by conc. HCl (0.5 ml) and boiled at 80oC for 1-3 h. Pouring the mixture into ice/ water, the obtained solid was separated and dried. Yield (74%); mp: > 300oC; IR (KBr) v/cm-1 1684 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 13.22 (1H, br s, -NH), 8.85 (1H, br d, J= 4.3 Hz, H-8), 8.55 (1H, br d, J= 7.7 Hz, H-6), 7.60 (1H, dd, J= 7.8, 4.8 Hz, H-7), 2.63 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.1 (C-2), 160.20 (C-5), 154.7 (C-3a), 150.8 (C-9a), 146.3 (C-8), 138.4 (C-6), 122.5 (C-5a), 113.2 (C-7), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C9H7N5OS (M)•+ 233.0371 found 233.0404.

2.1.2 Preparation of pyrido-triazolopyrimidines 2-11

At RT, K2CO3 (0.6 mmol) was added to a solution of 1 (0.5 mmol) in DMF (8 mL) and left to stir for 5 min. Thereafter, alkylhalide (1 mmol) was added and the reaction mixture was left to stir at RT for 18 h. Pouring the mixture into ice/ water, the solid was collected, washed with H2O and dried.

4-Ethyl-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-5(4H)-one (2) Yield (72%); mp: 200-202oC; IR (KBr) v/cm-1 1672 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.87 (1H, br d, J= 4.6 Hz, H-8), 8.60 (1H, br d, J= 7.8 Hz, H-6), 7.63 (1H, dd, J= 7.6, 4.9 Hz, H-7), 4.17 (2H, q, J= 7 Hz, H-1’), 2.65 (3H, s, -SCH3), 1.29 (3H, t, J= 7 Hz, H-2’); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.1 (C-2), 159.0 (C-5), 154.8 (C-3a), 151.5 (C-9a), 145.6 (C-8), 138.7 (C-6), 122.6 (C-5a), 112.6 (C-7), 39.60 (C-1’), 14.0 (-SCH3), 12.8 (C-2’); HRMS (EI), m/z Calcd. for C11H11N5OS (M)•+ 261.0684, found 261.0722.

4-Allyl-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-5(4H)-one (3) Yield (70%); mp: 165-167oC; IR (KBr) v/cm-1 1680 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.88 (1H, br d, J= 4.5 Hz, H-8), 8.61 (1H, br d, J= 7.8 Hz, H-6), 7.64 (1H, dd, J= 7, 5 Hz, H-7), 5.96 (1H, m, H-2’), 5.27 (1H, br d, J= 17.3 Hz, H-3a’), 5.18 (1H, br d, J= 10.4 Hz, H-3b’), 4.74 (2H, d, J= 3.7 Hz, H-1’), 2.65 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.0 (C-2), 159.0 (C-5), 154.9 (C-3a), 151.5 (C-9a), 145.7 (C-8), 138.8 (C-6), 131.6 (C-2’), 122.7 (C-5a), 117.8 (C-3’), 112.50 (C-7), 45.9 (C-1’), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C12H11N5OS (M)•+ 273.0684, found, 273.0731.

4-Benzyl-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-5(4H)-one (4) Yield (69%); mp: 190-192oC; IR (KBr) v/cm-1 1677 (C=O); 1H NMR (500 MHz, DMSO-d6): δ 8.87 (1H, br d, J= 4.5, Hz, H-8), 8.62 (1H, br d, J= 7.8 Hz, H-6), 7.64 (1H, dd, J= 7.8, 4.8 Hz, H-7), 7.43 (2H, br d, J= 7.6 Hz, H-2’/6’), 7.33 (2H, br t, J= 7.4 Hz, H-3’/5’), 7.29 (1H, br t, J= 7.1 Hz, H-4’), 5.33 (2H, s, H-7’), 2.65 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.5 (C-2), 159.4 (C-5), 155.0 (C-3a), 151.8 (C-9a), 145.7 (C-8), 138.8 (C-6), 136.1 (C-1’), 128.9 (C-3’/5’), 128.20 (C-2’/6’), 128.0 (C-4’), 122.7 (C-5a), 112.6 (C-7), 47.2 (C-7’), 14.00 (-SCH3); HRMS (EI), m/z Calcd. for C16H13N5OS (M)•+ 323.0841, found 323.0891.

4-(2-Methylbenzyl)-2-(methylthio)pyrido[3,2-e] [1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one (5) Yield (75%); mp: 206-208oC; IR (KBr) v/cm-1 1680 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.91 (1H, dd, J= 4.6 Hz, H-8), 8.63 (1H, br d, J= 7.8 Hz, H-6), 7.66 (1H, dd, J= 7.8, 4.8 Hz, H-7), 7.23 (1H, br d, J= 7.5 Hz, H-6’), 7.17 (1H, br t, J= 7.4 Hz, H-5’), 7.10 (1H, br d, J= 7.7 Hz, H-3’), 7.06 (1H, br t, J= 7.4 Hz, H-4’), 5.29 (2H, s, H-7’), 2.63 (3H, s, -SCH3), 2.44 (3H, s, Ar-Me); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.00 (C-2), 159.5 (C-5), 154.9 (C-3a), 151.9 (C-9a), 145.80 (C-8), 138.9 (C-6), 135.7 (C-1’), 133.8 (C-2’), 130.50 (C-3’), 127.6 (C-4’), 126.4 (C-5’), 126.1 (C-6’), 122.8 (C-5a), 112.6 (C-7), 45.2 (C-7’), 19.3 (Ar-Me), 14.00 (-SCH3); HRMS (EI), m/z Calcd. for C17H15N5OS (M)•+ 337.0997, found 337.1062.

4-(3-Methylbenzyl)-2-(methylthio)pyrido[3,2-e] [1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one (6) Yield (79%); mp: 192-194oC; IR (KBr) v/cm-1 1680 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.89 (1H, dd, J= 4.2, 1.6 Hz, H-8), 8.62 (1H, br d, J= 7.8 Hz, H-6), 7.64 (1H, dd, J= 7.8, 4.8 Hz, H-7), 7.24 (1H, br s, H-2’), 7.21 (2H, m, H-5’,6’), 7.08 (1H, br d, J= 7.4 Hz, H-4’), 5.29 (2H, s, H-7’), 2.65 (3H, s, -SCH3), 2.26 (3H, s, Ar-Me); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.0 (C-2), 159.40 (C-5), 154.90 (C-3a), 151.90 (C-9a), 145.70 (C-8), 138.80 (C-6), 138.0 (C-1’), 135.9 (C-3’), 128.8 (C-2’), 128.6 (C-5’), 128.5 (C-4’), 125.2 (C-6’), 122.7 (C-5a), 112.60 (C-7), 47.1 (C-7’), 21.40 (Ar-Me), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C17H15N5OS (M)•+ 337.0997, found 337.1062.

4-(3-Methoxybenzyl)-2-(methylthio)pyrido[3,2-e] [1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one (7) Yield (81%); mp: 175-177oC; IR (KBr) v/cm-1 1688 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.89 (1H, dd, J= 4.3, 2.1 Hz, H-8), 8.62 (1H, br d, J= 7.8 Hz, H-6), 7.62 (1H, br d, J= 5.7 Hz, H-7), 7.24 (1H, br t, J= 7.8 Hz, H-5’), 7.02 (1H, br s, H-2’), 6.98 (1H, br d, J= 7.6 Hz, H-6’), 6.85 (1H, br d, J= 8.1 Hz, H-4’), 5.29 (2H, s, H-7’), 3.72 (3H, s, O-Me), 2.65 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 162.9 (C-2), 159.7 (C-5), 159.4 (C-3’), 154.9 (C-3a), 151.7 (C-9a), 145.8 (C-8), 138.8 (C-6), 137.6 (C-1’), 130.0 (C-5’), 122.7 (C-5a), 120.1 (C-6’), 114.0 (C-4’), 113.2 (C-2’), 112.6 (C-7), 55.5 (O-Me), 47.1 (C-7’), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C17H15N5O2S (M)•+ 353.0946, found 353.0998.

3-((2-(Methylthio)-5-oxopyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-4(5H)-yl)methyl)-benzonitrile (8) Yield (80%); mp: 248-250oC; IR (KBr) v/ cm-1 1678 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.91 (1H, br s, H-8), 8.61 (1H, br d, J= 7.0, H-6), 7.90 (1H, br s, H-2’), 7.80 (1H, br d, J= 7 Hz, H-4’), 7.76 (1H, br d, J= 7, H-6’), 7.65 (1H, dd, J= 7.8, 4.9 Hz, H-7), 7.57 (1H, br t, J= 7.6 Hz, H-5’), 5.38 (2H, s, H-7’), 2.64 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 162.9 (C-2), 159.6 (C-5), 154.9 (C-3a), 151.9 (C-9a), 145.9 (C-8), 138.7 (C-6), 137.7 (C-1’), 132.9 (C-6’), 131.7 (C-2’), 131.1 (C-4’), 130.0 (C-5’), 131.1 (C-4’), 122.7 (C-5a), 119.2 (-C≡N), 112.8 (C-7), 46.6 (C-7’), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C17H12N6OS (M)•+ 348.0793, found 348.0821.

4-((2-(Methylthio)-5-oxopyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-4(5H)-yl)methyl)ben zonitrile (9) Yield (70%); mp: 279-281oC; IR (KBr) v/cm-1 1675 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.91 (1H, br s, H-8), 8.61 (1H, br d, J= 5.1 Hz, H-6), 7.81 (2H, br s, H-3’/5’), 7.65 (3H, m, H-7,2’/6’), 5.41 (2H, s, H-7’), 2.64 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 162.9 (C-2), 159.5 (C-5), 154.9 (C-3a), 151.8 (C-9a), 145.9 (C-8), 141.7 (C-1’), 138.8 (C-6), 132.8 (C-3’/5’), 128.8 (C-2’/6’), 122.7 (C-5a), 119.2 (-C≡N), 112.7 (C-7), 110.7 (C-4’), 46.9 (C-7’), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C17H12N6OS (M)•+ 348.0793, found 348.0821.

4-(4-Chlorobenzyl)-2-(methylthio)pyrido[3,2-e] [1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one (10) Yield (77%); mp: 250-252oC; IR (KBr) v/cm-1 1677 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.90 (1H, br d, J= 4.1 Hz, H-8), 8.62 (1H, br d, J= 7.8 Hz, H-6), 7.65 (1H, dd, J= 7.8, 4.8 Hz, H-7), 7.47 (2H, d, J= 7.5 Hz, H-3’/5’), 7.39 (2H, d, J= 7.5 Hz, H-2’/6’), 5.31 (2H, s, H-7’), 2.65 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 162.9 (C-2), 159.4 (C-5), 155.0 (C-3a), 151.8 (C-9a), 145.8 (C-8), 138.8 (C-6), 135.1 (C-1’), 132.6 (C-4’), 130.2 (C-2’/6’) 128.8 (C-3’/5’), 122.7 (C-5a), 112.7 (C-7), 46.6 (C-7’), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C16H12ClN5OS (M)•+ 357.0451, found 357.0503.

2-(3-(2-(Methylthio)-5-oxopyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidin-4(5H)-yl)prop-yl)-isoindoline-1,3-dione (11) Yield (71%); mp: 198-200oC; IR (KBr) v/cm-1 1681 (C=O); 1H NMR (700 MHz, DMSO-d6): δ 8.85 (1H, br d, J= 4.3 Hz, H-8), 8.55 (1H, br d, J= 7.8 Hz, H-6), 7.84 (4H, m , H-5’/6’, 4’/7’), 7.60 (1H, dd, J= 7.8, 4.2 Hz, H-7), 4.16 (2H, t, J = 7.0 Hz, CH2-8’), 3.70 (2H, t, J = 7 Hz, CH2- 10’), 2.14 (2H, quint, J = 7 Hz, CH2-9’), 2.55 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 168.4 (C-1’/3’), 162.9 (C-2), 159.2 (C-5), 154.8 (C-3a), 151.5 (C-9a), 145.5 (C-8), 138.6 (C-6), 134.9 (C-3a’/7a’), 132.0 (C-5’/6’), 123.5 (C-4’/7’), 122.7 (C-5a), 112.6 (C-7), 41.8 (CH2-8’), 35.7 (CH2-10’), 26.1 (CH2-9’), 13.9 (-SCH3); HRMS (EI), m/z Calcd. for C20H16N6O3S (M)•+ 420.1005, found 420.1063.

2.1.3 Preparation of 2-(Methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidine-5(4H)-thione (12)

Boiling an equimolar amount of 1 and P2S5 (1 mmol) in absolute pyridine (10 mL) for 3-4 h. After that, the reaction mixture was cooled and poured into ice/water, the obtained yellow solid was washed thoroughly with water and dried. Yield (90%); mp: 292-294oC; IR (KBr) v/cm-1 1248 (C=S); 1H NMR (700 MHz, DMSO-d6): δ 8.94 (1H, br d, J= 4.3 Hz, H-8), 8.62 (1H, br d, J= 7 Hz, H-6), 7.67 (1H, dd, J= 7.8, 4.6 Hz, H-7), 2.66 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 186.1 (C-5), 164.0 (C-2), 155.5 (C-3a), 149.8 (C-9a), 143.0 (C-8), 141.6 (C-6), 124.6 (C-5a), 123.2 (C-7), 14.1 (-SCH3); HRMS (EI), m/z Calcd. for C9H7N5S2 (M)•+ 249.0143, found 249.0187.

2.1.4 Preparation of pyrido-triazolopyrimidines 13-16

Over a period of 10 min at RT, K2CO3 (1 mmol) was added to a stirred solution of 12 (0.5 mmol) in DMF (8 mL). Then, alkylhalides (1.5 mmol) was added and kept stirring in the reaction mixture at 80 oC for 20 h. The mixture was poured into ice/water, the solid collected and dried.

5-(Ethylthio)-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidine (13) Yield (58%); mp: 159161oC; 1H NMR (700 MHz, DMSO-d6): δ 9.06 (1H, br d, J= 4.2 Hz, H-8), 8.66 (1H, br d, J= 8.1 Hz, H-6), 7.74 (1H, dd, J= 8.1, 4.6 Hz, H-7), 3.41 (2H, q, J= 7.3 Hz, H-1’), 2.69 (3H, s, -SCH3), 1.42 (3H, t, J= 7.3 Hz, H-2’); 13C NMR (175 MHz, DMSO-d6): δ ppm 168.2 (C-5), 165.3 (C-2), 156.1 (C-3a), 155.0 (C-9a), 143.5 (C-8), 135.7 (C-6), 122.8 (C-5a), 113.7 (C-7), 24.7 (C-1’), 14.4 (C-2’), 13.9 (-SCH3); HRMS (EI), m/z Calcd. for C11H11N5S2 (M)•+ 277.0456, found 277.0498.

5-(Allylthio)-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidine (14) Yield (50%); mp: 165167oC; 1H NMR (700 MHz, DMSO-d6): δ 9.08 (1H, br d, J= 4.2 Hz, H-8), 8.70 (1H, br d, J= 8.1 Hz, H-6), 7.75 (1H, dd, J= 8.1, 4.6 Hz, H-7), 5.99 (1H, m, H-2’), 5.40 (1H, br d, J= 17.3 Hz, H-3a’), 5.20 (1H, br d, J= 10.4 Hz, H-3b’), 4.20 (2H, d, J= 3.7 Hz, H-1’), 2.70 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 167.6 (C-5), 165.2 (C-2), 156.1 (C-3a), 154.5 (C-9a), 143.3 (C-8), 135.8 (C-6), 132.8 (C-2’), 122.7 (C-5a), 119.7 (C-3’), 113.4 (C-7), 32.8 (-CH2-1’), 13.9 (-SCH3); HRMS (EI), m/z Calcd. for C12H11N5S2 (M)•+ 289.0456, found 289.0506.

5-(Benzylthio)-2-(methylthio)pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidine (15) Yield (54%); mp: 182184oC; 1H NMR (700 MHz, DMSO-d6): δ 9.07 (1H, br d, J= 4.4 Hz, H-8), 8.69 (1H, br d, J= 8.1 Hz, H-6), 7.74 (1H, dd, J= 8.1, 4.7 Hz, H-7), 7.53 (2H, br d, J= 7.6 Hz, H-2’/6’), 7.37 (2H, br t, J= 7.5 Hz, H-3’/5’), 7.30 (1H, br t, J= 7.6 Hz, H-4’), 4.71 (2H, s, -CH2-7’), 2.71 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 167.7 (C-5), 165.4 (C-2), 156.2 (C-3a), 154.9 (C-9a), 143.6 (C-8), 136.8 (C-1’), 135.8 (C-6), 129.9 (C-3’/5’), 129.1 (C-2’/6’), 128.9 (C-4’), 122.9 (C-5a), 113.2 (C-7), 34.1 (-CH2-7’), 13.9 (-SCH3); HRMS (EI), m/z Calcd. for C16H13N5S2 (M)•+ 339.0612, found 339.0676.

5-((2-Methylbenzyl)thio)-2-(methylthio) pyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimidine (16) Yield (61%); mp: 179-181oC; 1H NMR (700 MHz, DMSO-d6): δ 9.07 (1H, br d, J= 4.3 Hz, H-8), 8.69 (1H, br d, J= 8.1 Hz, H-6), 7.73 (1H, dd, J= 8.1, 4.6 Hz, H-7), 7.50 (1H, br d, J= 7.4 Hz, H-6’), 7.24 (2H, m, H-3’/5’), 7.19 (1H, br t, J= 7.6 Hz, H-4’), 4.69 (2H, s, -CH2-7’), 2.71 (3H, s, -SCH3), 2.44 (3H, Ar-CH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 167.9 (C-5), 165.4 (C-2), 156.2 (C-3a), 154.9 (C-9a), 143.6 (C-8), 137.4 (C-1’), 135.8 (C-6), 134.0 (C-2’), 130.9 (C-3’), 130.7 (C-4’), 128.5 (C-5’), 126.7 (C-6’), 122.9 (C-5a), 113.2 (C-7), 32.7 (-CH2-7’), 19.4 (Ar-CH3), 13.9 (-SCH3); HRMS (EI), m/z Calcd. for C17H15N5S2 (M)•+ 353.0769, found 353.0832

2.1.5 Preparation of 5-Chloro-2-(methylthio) pyrido[3,2-e][1,2,4]triazolo[1,5-a]pyrimi-dine (17)

An amount of 2 mmol from pyrido-triazolopyrimidine (1) was boiled with POCl3 (2 mL) in C6H6 (14 mL) for 5 h; then the solvent was removed by evaporation and the residue neutralized with a saturated aqueous solution of K2CO3 (6 ml). The obtained solid was collected and dried. Yield (75%); mp: 250-252oC; 1H NMR (700 MHz, DMSO-d6): δ 8.82 (1H, br d, J= 4.4 Hz, H-8), 8.55 (1H, br d, J= 8.1 Hz, H-6), 7.62 (1H, dd, J= 8.1, 4.6 Hz, H-7), 2.63 (3H, s, -SCH3); 13C NMR (175 MHz, DMSO-d6): δ ppm 163.1 (C-2), 160.2 (C-3a), 154.7 (C-9a), 150.8 (C-5), 146.3 (C-8), 137.5 (C-6), 122.5 (C-5a), 113.2 (C-7), 14.0 (-SCH3); HRMS (EI), m/z Calcd. for C9H6ClN5S (M)•+ 251.0032, found 251.0092.

2.2 Antioxidant assays

In our previous paper [8,13], we have reported in detail the methodology routes for determination of DPPH radical scavenging activity %, FRAP values and reducing power of the target compounds.

Ethical approval: The conducted research is not related to either human or animal use.

3 Results and Discussion

3.1 Chemistry

The 3- amino- 5- (methylthio) - 1, 2, 4- triazole or 5-amino-N-(2,6-dichlorophenyl)-1,2,4-triazole-3-sulfonamide was reacted with 2- chloronicotinic acid to afford the target (1) has been described [2,3]. Herein, the synthesized 2-hydrazinonicotonic acid (A) [14] was reacted with dimethyl-N-cyanoimidodithio carbonte to give the intermediate (B) (Scheme 1). Then, the corresponding 2-methylthio-pyrido-triazolopyrimidin-5-one (1) was obtained in a good yield of 74% by treatment of the intermediate B with Conc. HCl. The target 1 was characterized by NMR, IR and MS spectral analyses. The IR spectrum of 1 was characterized by a strong stretching (C=O) peak at 1684 cm-1. Reaction of 1 with alkyl halides furnished the N-alkylated pyrido-triazolopyrimidines (2-11) in 69-81% yields (Scheme 1, Table 1). The IR spectra of 2-11 showed the characteristic (C=O) group absorption bands at 1670-1688 cm-1. Boiling equimolar amounts of 1 and P2S5 in pyridine for 3-4 h has furnished the respective 2-methylthio-pyrido-triazolopyrimidin-5-thione (12) as yellow solid in yield of 90%. The structure of product 12 was proved with IR and 13C NMR analyses, where C=S group exhibited an intrinsic a weak absorption peak at 1248 cm-1 and a resonance peak at 186.1 ppm, respectively. The expected thioether products (13-16) were obtained from the reaction of 12 with the appropriate alkyl halides in basic medium. The carbonyl group of 1 was successfully transformed into imidoyl chloride group in 17 by employing POCl3 as a chlorinating agent. Complete disappearance of the carbonyl peak at 1684 cm-1 in the IR spectrum of 1, confirmed the production of 17. Taking into account the NMR data of structural related compounds [9,15,16], the parent structure 2-methylthio-pyrido-triazolopyrimidine and its derivatives were simply confirmed by 1H NMR, that showed one AMX spin coupling system and a singlet of a 2-methylthio group at about 2.65 ppm that was recorded at about 14 ppm in all 13C NMR spectra. This spin coupling system was interpretable for the three protons of pyrido-ring, i.e. H-8 and H-6 (often broad doublet, each) and H-7 (dd) at about δ 8.9 – 7.5 ppm. In all 13C NMR spectra, the parent structure of all products exhibited nine signals, including the most downfield thionated (C-2) and lactam-carbonyl carbon (C-5) at about 163 and 160 together with the characteristic three aromatic –CH-carbons at about 146, 139 and 113 ppm for C-8, 6 and 7 (1 and 2-11). The C-5 showed a characteristic δ-value at 186.1 ppm for thiocarbonyl function in compound 12, while in the thioalkyl/aralkyl derivatives 13-16 it was assigned as the most downfield carbon at about 168 ppm.

Scheme 1 Synthesis of the new products 1-17.
Scheme 1

Synthesis of the new products 1-17.

Table 1

The chemical structures of the products 1-17.

Cpd.RCpd.R
2,137
3,148
4,159
5,1610
611

3.2 Antioxidant activity

The DPPH, FRAP and RPC assays were applied to assess the in vitro antioxidant activity of the pyrido-triazolopyrimidines (1-17). The obtained results were presented in figures 1-3 and compared with standard synthetic antioxidant. The target pyrido-triazolopyrimidines (1-17) showed various antioxidant activities relative to BHT. Figure: 1 presented the pyrido-triazolopyrimidines (1-17) inhibitory effects at a concentration of 0.5 mg/ml, the same as DPPH radical. The pyrido-triazolopyrimidines 12 and 15 were found to exhibit high DPPH radical scavenging activity among the tested products, however, lower than BHT.

Figure: 1 DPPH free radical scavenging activity of compounds 1-17.
Figure: 1

DPPH free radical scavenging activity of compounds 1-17.

Figure: 2 Reducing power capability (absorbance at 700 nm) of compounds 1-17.
Figure: 2

Reducing power capability (absorbance at 700 nm) of compounds 1-17.

Figure: 3 Ferric reducing antioxidant power (FRAP) of compounds 1-17.
Figure: 3

Ferric reducing antioxidant power (FRAP) of compounds 1-17.

Pyrido-triazolopyrimidine (17) demonstrated moderate scavenging activity in relation to the compounds 12 and 15. Whereas compounds 1-11 appeared less active (Figure: 1). The reducing power capacities of pyrido-triazolopyrimidines 1-17 were compared with BHT (Figure: 2). Compounds 12, 15 and 17 showed the highest antioxidant activity at a concentration of 0.5 mg/mL in regards to the other pyrido-triazolopyrimidines, whereas 1, 5, 8, 10 and 16 exhibited moderate effects. However, at the same concentration (0.5 mg/mL), the targets 1-17 appeared less active than BHT. Figure 3 showed that the target pyrido-triazolopyrimidines 12 and 15 exhibited the highest activity and their values of FRAP are 973 and 1143 (μmol Trolox/100 g). Compounds 14, 16 and 17 were found to possess relative comparable antioxidant activity to 12 and 15. Meanwhile, compounds 2, 3, 5, 8, 10 and 13 demonstrated moderate activity (a higher FRAP value is the greatest antioxidant activity). Additionally, compounds 1, 4, 6 and 9 showed the lowest activity. From the summarized results, it was noticed that the targets antioxidant is correlated with substituents on the pyrido-pyrimidine ring. As presented in Table 2, the highest DPPH scavenging activity of 12 and 15 when compared with other pyrido-triazolopyrimidines, may be due to the existence of a thiocarbonyl group in 12 and its transformed thiother in 15, however, compound 15 appeared to be the most active. In accordance with our reported antioxidant results [13], compound 12 could have the same behavior as the reported benzotriazoloquinazolines and expected to undergo sequential proton loss electron transfer (SPLET) mechanism as illustrated in scheme 2. Thus, compound 12 may be showing a lower DE than the others.

Scheme 2 Reasonable mechanism of the redox reaction or antioxidant activity of product 12.
Scheme 2

Reasonable mechanism of the redox reaction or antioxidant activity of product 12.

Generally, in redox reactions of organic compounds, if a C-atom loses a bond to H and gains a bond to a heteroatom (or to another C-atom), it is considered to be an oxidation reaction because the H-element is the least electronegative one. Thus, in the dehydrogenation process the C-atom undergoes an overall loss of electron density and loss of electrons is oxidation. Contrary, in the hydrogenation or reduction of an organic compound a C-atom forms a new bond to H and loses a bond to a heteroatom (or to another C-atom). Accordingly, chemical modification on the parent 1 furnished 217 with high diversity in antioxidant activity; in particular, the conversion of C=O in 1 into C=S in 12, has resulted in the increase of antioxidant effects. Similarly, the formation of 13-16 derivatives from 12 positively improved in the activity profiles, which is probably explained due to the presence of an electron-rich sulfur-containing moiety (-S-R).

4 Conclusions

A total of seventeen new 2-methylthio-pyrido-triazolopyrimidines were successfully prepared by the reaction of dimethyl-N-cyanoimidodithiocarbonate and hydrazine-pyridine carboxylic acid as the reactants. In all three assays used, the 5-thione (12) and 5-thiobenzyl (15) products have shown the strongest antioxidant effects.

Acknowledgements

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project no. RG 1435-068.

  1. Conflict of interest: The authors declare no conflicts of interest.

  2. Authors’ contributions: First, Third and Fourth authors participated in the designing and writing the proposal of this research point, and synthesis-analysis of the products. The second author conducted the biological studies and presented the results. All authors wrote, read and approved the final manuscript.

References

[1] Al-Salahi R., Geffken D., Koellner M., A new series of 2-Alkoxy(aralkoxy)[1,2,4] triazolo[1,5-aquinazolin-5-ones as Adenosine Receptor Antagonists, Chem. Pharm. Bull., 2011, 59, 730–733.10.1248/cpb.59.730Search in Google Scholar PubMed

[2] Bereznak J.F., Chan D.M.-T., Geffken D., Hanagan M.A., Lepone G.E., Pasteris R.J., Swann S.L., Preparation of fungicidal tricyclic 1,2,4-triazoles, 2008 WO 2008103357 A1 20080828.Search in Google Scholar

[3] Wegner P., Krueger M., Krueger G., Head J., Rees R., Johann G., Pyrido[3,2-e][1,2,4]triazolo[1,5-apyrimidine-2-sulphonamides, processes for their preparation, and their use as herbicides, plant growth regulators and fungicides. Ger. Offen, 1990 DE 3825041 A1 19900215.Search in Google Scholar

[4] Alagarsamy V., Solomon V.R., Murugan M., Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-aquinazolin-5-ones as new class of H1-antihistaminic agents, Bioorg. Med. Chem 2007, 15, 4009–4015.10.1016/j.bmc.2007.04.001Search in Google Scholar PubMed

[5] Abuelizz A.H., El-Dib R.A., Marzouk M., Al-Salahi R., In vitro evaluation of new 2-phenoxy-benzog[1,2,4]triazolo[1,5-a quinazoline derivatives as antimicrobial agents, Microb. Pathog., 2018, 117, 60–67.10.1016/j.micpath.2018.02.018Search in Google Scholar PubMed

[6] Al-Salahi R., Al-Omar M., Alswaidan I., Marzouk M., Alsenousy W., Amr A.E., Antiviral activities of some synthesized methylsulfanyltriazoloquinazoline derivatives, Res. Chem. Inter., 2015, 41, 151–161.10.1007/s11164-013-1177-1Search in Google Scholar

[7] Al-Salahi R., El-Tahir K.-E., Alswaidan I., Lolak N., Hamidaddin M., Marzouk M., Biological effects of a new set 1,2,4-triazolo[1,5-aquinazolines on heart rate and blood pressure, Chem. Cent. J., 2014, 8, 3.10.1186/1752-153X-8-3Search in Google Scholar PubMed PubMed Central

[8] Al-Salahi R., Anouar E.H., Marzouk M., Taie H.A., Abuelizz H.A., Screening and evaluation of antioxidant activity of some 1,2,4-triazolo[1,5-aquinazolinederivatives, Future Med. Chem., 2017, 10, 379–390.10.4155/fmc-2017-0224Search in Google Scholar PubMed

[9] Al-Salahi R., Marzouk M., Awad G., Al-Omar M., Ezzeldin E., Antimicrobial activity of newly synthesized methylsulfanyltriazoloquinazoline derivatives, J. Pharm. Pharmacol. 2013, 65, 790–797.10.1111/jphp.12039Search in Google Scholar PubMed

[10] Al-Salahi R., Marzouk M., Eldeen A.G., Alanazi A., Al-Omar M., Fouda M., Cytotoxic and Anti-inflammatory Active Methylsulfanyl-triazoloquinazolines, J. pure appl. Microb., 2013, 7 189–198.10.3390/molecules18021434Search in Google Scholar PubMed PubMed Central

[11] Al-Salahi R., Marzouk M., Ashour A.-E., Alswiadan I., Synthesis and antitumor activity of 1,2,4-triazolo[1,5-aquinazolines, Asian J. Chem., 2014, 26, 2173–2176.10.14233/ajchem.2014.16849Search in Google Scholar

[12] Hossan A.S., Abu-Melha H.M., Al-Omar M.A., Amr A.E., Synthesis and antimicrobial activity of some new pyrimidinone and oxazinone derivatives fused with thiophene rings using 2-chloro-6-ethoxy-4-acetylpyridine as starting material, Molecules, 2012, 17, 13642–1355.10.3390/molecules171113642Search in Google Scholar PubMed PubMed Central

[13] Almehizia A., Abuelizz H., Taie H.A., ElHassane A., Marzouk M., Al-Salahi R., Investigation the antioxidant activity of benzogtriazoloquinazolines correlated with a DFT study, Saudi Pharm. J., 2019, 27, 133–137.10.1016/j.jsps.2018.09.006Search in Google Scholar PubMed PubMed Central

[14] Meszaros L.K., Dose A., Biagini S.C., Blower P.J., Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium, Dalton Trans., 2011, 40, 6260–6267.10.1039/c0dt01608jSearch in Google Scholar PubMed

[15] Al-Salahi R., Marzouk M., Synthesis of novel 2-phenoxybenzog [1,2,4]triazolo[1,5-a]quinazoline derivatives starting from diphenyl-N-cyanoimidocarbonate, Russian J. Gen. Chem., 2016, 86, 1741–1746.10.1134/S1070363216070331Search in Google Scholar

[16] Al-Salahi R., Marzouk M., Ghabbour H., Kun F.H., Synthesis of novel 2-(Methylthio)benzo-g[1,2,4]triazolo[1,5-aquinazolin-5-(4H-one and its derivatives, Letter Org. Chem., 2014, 11, 759–767.10.2174/1570178611666140813205111Search in Google Scholar

Received: 2019-01-06
Accepted: 2019-07-23
Published Online: 2019-10-12

© 2019 Hatem A. Abuelizz et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. Regular Articles
  2. Research on correlation of compositions with oestrogenic activity of Cistanche based on LC/Q-TOF-MS/MS technology
  3. Efficacy of Pyrus elaeagnifolia subsp. elaeagnifolia in acetic acid–induced colitis model
  4. Anti-inflammatory and antinociceptive features of Bryonia alba L.: As a possible alternative in treating rheumatism
  5. High efficiency liposome fusion induced by reducing undesired membrane peptides interaction
  6. Prediction of the Blood-Brain Barrier Permeability Using RP-18 Thin Layer Chromatography
  7. Phytic Acid Extracted from Rice Bran as a Growth Promoter for Euglena gracilis
  8. Development of a validated spectrofluorimetric method for assay of sotalol hydrochloride in tablets and human plasma: application for stability-indicating studies
  9. Topological Indices of Hyaluronic Acid-Paclitaxel Conjugates’ Molecular Structure in Cancer Treatment
  10. Thermodynamic properties of the bubble growth process in a pool boiling of water-ethanol mixture two-component system
  11. Critical Roles of the PI3K-Akt-mTOR Signaling Pathway in Apoptosis and Autophagy of Astrocytes Induced by Methamphetamine
  12. Characteristics of Stable Hydrogen and Oxygen Isotopes of Soil Moisture under Different Land Use in Dry Hot Valley of Yuanmou
  13. Specific, highly sensitive and simple spectrofluorimetric method for quantification of daclatasvir in HCV human plasma patients and in tablets dosage form
  14. Chromium-modified cobalt molybdenum nitrides as catalysts for ammonia synthesis
  15. Langerhans cell-like dendritic cells treated with ginsenoside Rh2 regulate the differentiation of Th1 and Th2 cells in vivo
  16. Identification of Powdery Mildew Blumeria graminis f. sp. tritici Resistance Genes in Selected Wheat Varieties and Development of Multiplex PCR
  17. Computational Analysis of new Degree-based descriptors of oxide networks
  18. The Use Of Chemical Composition And Additives To Classify Petrol And Diesel Using Gas Chromatography–Mass Spectrometry And Chemometric Analysis: A Uk Study
  19. Minimal Energy Tree with 4 Branched Vertices
  20. Jatropha seed oil derived poly(esteramide-urethane)/ fumed silica nanocomposite coatings for corrosion protection
  21. Calculating topological indices of certain OTIS interconnection networks
  22. Energy storage analysis of R125 in UIO-66 and MOF-5 nanoparticles: A molecular simulation study
  23. Velvet Antler compounds targeting major cell signaling pathways in osteosarcoma - a new insight into mediating the process of invasion and metastasis in OS
  24. Effects of Azadirachta Indica Leaf Extract, Capping Agents, on the Synthesis of Pure And Cu Doped ZnO-Nanoparticles: A Green Approach and Microbial Activity
  25. Aqueous Micro-hydration of Na+(H2O)n=1-7 Clusters: DFT Study
  26. A proposed image-based detection of methamidophos pesticide using peroxyoxalate chemiluminescence system
  27. Phytochemical screening and estrogenic activity of total glycosides of Cistanche deserticola
  28. Biological evaluation of a series of benzothiazole derivatives as mosquitocidal agents
  29. Chemical pretreatments of Trapa bispinosa's peel (TBP) biosorbent to enhance adsorption capacity for Pb(ll)
  30. Dynamic Changes in MMP1 and TIMP1 in the Antifibrotic Process of Dahuang Zhechong Pill in Rats with Liver Fibrosis
  31. The Optimization and Production of Ginkgolide B Lipid Microemulsion
  32. Photodynamic Therapy Enhanced the Antitumor Effects of Berberine on HeLa Cells
  33. Chiral and Achiral Enantiomeric Separation of (±)-Alprenolol
  34. Correlation of Water Fluoride with Body Fluids, Dental Fluorosis and FT4, FT3 –TSH Disruption among Children in an Endemic Fluorosis area in Pakistan
  35. A one-step incubation ELISA kit for rapid determination of dibutyl phthalate in water, beverage and liquor
  36. Free Radical Scavenging Activity of Essential Oil of Eugenia caryophylata from Amboina Island and Derivatives of Eugenol
  37. Effects of Blue and Red Light On Growth And Nitrate Metabolism In Pakchoi
  38. miRNA-199a-5p functions as a tumor suppressor in prolactinomas
  39. Solar photodegradation of carbamazepine from aqueous solutions using a compound parabolic concentrator equipped with a sun tracking system
  40. Influence of sub-inhibitory concentration of selected plant essential oils on the physical and biochemical properties of Pseudomonas orientalis
  41. Preparation and spectroscopic studies of Fe(II), Ru(II), Pd(II) and Zn(II) complexes of Schiff base containing terephthalaldehyde and their transfer hydrogenation and Suzuki-Miyaura coupling reaction
  42. Complex formation in a liquid-liquid extraction-chromogenic system for vanadium(IV)
  43. Synthesis, characterization (IR, 1H, 13C & 31P NMR), fungicidal, herbicidal and molecular docking evaluation of steroid phosphorus compounds
  44. Analysis and Biological Evaluation of Arisaema Amuremse Maxim Essential Oil
  45. A preliminary assessment of potential ecological risk and soil contamination by heavy metals around a cement factory, western Saudi Arabia
  46. Anti- inflammatory effect of Prunus tomentosa Thunb total flavones in LPS-induced RAW264.7 cells
  47. Collaborative Influence of Elevated CO2 Concentration and High Temperature on Potato Biomass Accumulation and Characteristics
  48. Methods of extraction, physicochemical properties of alginates and their applications in biomedical field – a review
  49. Characteristics of liposomes derived from egg yolk
  50. Preparation of ternary ZnO/Ag/cellulose and its enhanced photocatalytic degradation property on phenol and benzene in VOCs
  51. Influence of Human Serum Albumin Glycation on the Binding Affinities for Natural Flavonoids
  52. Synthesis and antioxidant activity of 2-methylthio-pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidines
  53. Comparative study on the antioxidant activities of ten common flower teas from China
  54. Molecular Properties of Symmetrical Networks Using Topological Polynomials
  55. Synthesis of Co3O4 Nano Aggregates by Co-precipitation Method and its Catalytic and Fuel Additive Applications
  56. Phytochemical analysis, Antioxidant and Antiprotoscolices potential of ethanol extracts of selected plants species against Echinococcus granulosus: In-vitro study
  57. Silver nanoparticles enhanced fluorescence for sensitive determination of fluoroquinolones in water solutions
  58. Simultaneous Quantification of the New Psychoactive Substances 3-FMC, 3-FPM, 4-CEC, and 4-BMC in Human Blood using GC-MS
  59. Biodiesel Production by Lipids From Indonesian strain of Microalgae Chlorella vulgaris
  60. Miscibility studies of polystyrene/polyvinyl chloride blend in presence of organoclay
  61. Antibacterial Activities of Transition Metal complexes of Mesocyclic Amidine 1,4-diazacycloheptane (DACH)
  62. Novel 1,8-Naphthyridine Derivatives: Design, Synthesis and in vitro screening of their cytotoxic activity against MCF7 cell line
  63. Investigation of Stress Corrosion Cracking Behaviour of Mg-Al-Zn Alloys in Different pH Environments by SSRT Method
  64. Various Combinations of Flame Retardants for Poly (vinyl chloride)
  65. Phenolic compounds and biological activities of rye (Secale cereale L.) grains
  66. Oxidative degradation of gentamicin present in water by an electro-Fenton process and biodegradability improvement
  67. Optimizing Suitable Conditions for the Removal of Ammonium Nitrogen by a Microbe Isolated from Chicken Manure
  68. Anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Haloxylon salicornicum aqueous fraction
  69. The anti-corrosion behaviour of Satureja montana L. extract on iron in NaCl solution
  70. Interleukin-4, hemopexin, and lipoprotein-associated phospholipase A2 are significantly increased in patients with unstable carotid plaque
  71. A comparative study of the crystal structures of 2-(4-(2-(4-(3-chlorophenyl)pipera -zinyl)ethyl) benzyl)isoindoline-1,3-dione by synchrotron radiation X-ray powder diffraction and single-crystal X-ray diffraction
  72. Conceptual DFT as a Novel Chemoinformatics Tool for Studying the Chemical Reactivity Properties of the Amatoxin Family of Fungal Peptides
  73. Occurrence of Aflatoxin M1 in Milk-based Mithae samples from Pakistan
  74. Kinetics of Iron Removal From Ti-Extraction Blast Furnace Slag by Chlorination Calcination
  75. Increasing the activity of DNAzyme based on the telomeric sequence: 2’-OMe-RNA and LNA modifications
  76. Exploring the optoelectronic properties of a chromene-appended pyrimidone derivative for photovoltaic applications
  77. Effect of He Qi San on DNA Methylation in Type 2 Diabetes Mellitus Patients with Phlegm-blood Stasis Syndrome
  78. Cyclodextrin potentiometric sensors based on selective recognition sites for procainamide: Comparative and theoretical study
  79. Greener synthesis of dimethyl carbonate from carbon dioxide and methanol using a tunable ionic liquid catalyst
  80. Nonisothermal Cold Crystallization Kinetics of Poly(lactic acid)/Bacterial Poly(hydroxyoctanoate) (PHO)/Talc
  81. Enhanced adsorption of sulfonamide antibiotics in water by modified biochar derived from bagasse
  82. Study on the Mechanism of Shugan Xiaozhi Fang on Cells with Non-alcoholic Fatty Liver Disease
  83. Comparative Effects of Salt and Alkali Stress on Antioxidant System in Cotton (Gossypium Hirsutum L.) Leaves
  84. Optimization of chromatographic systems for analysis of selected psychotropic drugs and their metabolites in serum and saliva by HPLC in order to monitor therapeutic drugs
  85. Electrocatalytic Properties of Ni-Doped BaFe12O19 for Oxygen Evolution in Alkaline Solution
  86. Study on the removal of high contents of ammonium from piggery wastewater by clinoptilolite and the corresponding mechanisms
  87. Phytochemistry and toxicological assessment of Bryonia dioica roots used in north-African alternative medicine
  88. The essential oil composition of selected Hemerocallis cultivars and their biological activity
  89. Mechanical Properties of Carbon Fiber Reinforced Nanocrystalline Nickel Composite Electroforming Deposit
  90. Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
  91. Topical Issue on Applications of Mathematics in Chemistry
  92. Zagreb Connection Number Index of Nanotubes and Regular Hexagonal Lattice
  93. The Sanskruti index of trees and unicyclic graphs
  94. Valency-based molecular descriptors of Bakelite network BNmn
  95. Computing Topological Indices for Para-Line Graphs of Anthracene
  96. Zagreb Polynomials and redefined Zagreb indices of Dendrimers and Polyomino Chains
  97. Topological Descriptor of 2-Dimensional Silicon Carbons and Their Applications
  98. Topological invariants for the line graphs of some classes of graphs
  99. Words for maximal Subgroups of Fi24
  100. Generators of Maximal Subgroups of Harada-Norton and some Linear Groups
  101. Special Issue on POKOCHA 2018
  102. Influence of Production Parameters on the Content of Polyphenolic Compounds in Extruded Porridge Enriched with Chokeberry Fruit (Aronia melanocarpa (Michx.) Elliott)
  103. Effects of Supercritical Carbon Dioxide Extraction (SC-CO2) on the content of tiliroside in the extracts from Tilia L. flowers
  104. Impact of xanthan gum addition on phenolic acids composition and selected properties of new gluten-free maize-field bean pasta
  105. Impact of storage temperature and time on Moldavian dragonhead oil – spectroscopic and chemometric analysis
  106. The effect of selected substances on the stability of standard solutions in voltammetric analysis of ascorbic acid in fruit juices
  107. Determination of the content of Pb, Cd, Cu, Zn in dairy products from various regions of Poland
  108. Special Issue on IC3PE 2018 Conference
  109. The Photocatalytic Activity of Zns-TiO2 on a Carbon Fiber Prepared by Chemical Bath Deposition
  110. N-octyl chitosan derivatives as amphiphilic carrier agents for herbicide formulations
  111. Kinetics and Mechanistic Study of Hydrolysis of Adenosine Monophosphate Disodium Salt (AMPNa2) in Acidic and Alkaline Media
  112. Antimalarial Activity of Andrographis Paniculata Ness‘s N-hexane Extract and Its Major Compounds
  113. Special Issue on ABB2018 Conference
  114. Special Issue on ICCESEN 2017
  115. Theoretical Diagnostics of Second and Third-order Hyperpolarizabilities of Several Acid Derivatives
  116. Determination of Gamma Rays Efficiency Against Rhizoctonia solani in Potatoes
  117. Studies On Compatibilization Of Recycled Polyethylene/Thermoplastic Starch Blends By Using Different Compatibilizer
  118. Liquid−Liquid Extraction of Linalool from Methyl Eugenol with 1-Ethyl-3-methylimidazolium Hydrogen Sulfate [EMIM][HSO4] Ionic Liquid
  119. Synthesis of Graphene Oxide Through Ultrasonic Assisted Electrochemical Exfoliation
  120. Special Issue on ISCMP 2018
  121. Synthesis and antiproliferative evaluation of some 1,4-naphthoquinone derivatives against human cervical cancer cells
  122. The influence of the grafted aryl groups on the solvation properties of the graphyne and graphdiyne - a MD study
  123. Electrochemical modification of platinum and glassy carbon surfaces with pyridine layers and their use as complexing agents for copper (II) ions
  124. Effect of Electrospinning Process on Total Antioxidant Activity of Electrospun Nanofibers Containing Grape Seed Extract
  125. Effect Of Thermal Treatment Of Trepel At Temperature Range 800-1200˚C
  126. Topical Issue on Agriculture
  127. The effect of Cladophora glomerata exudates on the amino acid composition of Cladophora fracta and Rhizoclonium sp.
  128. Influence of the Static Magnetic Field and Algal Extract on the Germination of Soybean Seeds
  129. The use of UV-induced fluorescence for the assessment of homogeneity of granular mixtures
  130. The use of microorganisms as bio-fertilizers in the cultivation of white lupine
  131. Lyophilized apples on flax oil and ethyl esters of flax oil - stability and antioxidant evaluation
  132. Production of phosphorus biofertilizer based on the renewable materials in large laboratory scale
  133. Human health risk assessment of potential toxic elements in paddy soil and rice (Oryza sativa) from Ugbawka fields, Enugu, Nigeria
  134. Recovery of phosphates(V) from wastewaters of different chemical composition
  135. Special Issue on the 4th Green Chemistry 2018
  136. Dead zone for hydrogenation of propylene reaction carried out on commercial catalyst pellets
  137. Improved thermally stable oligoetherols from 6-aminouracil, ethylene carbonate and boric acid
  138. The role of a chemical loop in removal of hazardous contaminants from coke oven wastewater during its treatment
  139. Combating paraben pollution in surface waters with a variety of photocatalyzed systems: Looking for the most efficient technology
  140. Special Issue on Chemistry Today for Tomorrow 2019
  141. Applying Discriminant and Cluster Analyses to Separate Allergenic from Non-allergenic Proteins
  142. Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients
  143. Chemomertic Risk Assessment of Soil Pollution
  144. New composite sorbent for speciation analysis of soluble chromium in textiles
  145. Photocatalytic activity of NiFe2O4 and Zn0.5Ni0.5Fe2O4 modified by Eu(III) and Tb(III) for decomposition of Malachite Green
  146. Photophysical and antibacterial activity of light-activated quaternary eosin Y
  147. Spectral properties and biological activity of La(III) and Nd(III) Monensinates
  148. Special Issue on Monitoring, Risk Assessment and Sustainable Management for the Exposure to Environmental Toxins
  149. Soil organic carbon mineralization in relation to microbial dynamics in subtropical red soils dominated by differently sized aggregates
  150. A potential reusable fluorescent aptasensor based on magnetic nanoparticles for ochratoxin A analysis
  151. Special Issue on 13th JCC 2018
  152. Fluorescence study of 5-nitroisatin Schiff base immobilized on SBA-15 for sensing Fe3+
  153. Thermal and Morphology Properties of Cellulose Nanofiber from TEMPO-oxidized Lower part of Empty Fruit Bunches (LEFB)
  154. Encapsulation of Vitamin C in Sesame Liposomes: Computational and Experimental Studies
  155. A comparative study of the utilization of synthetic foaming agent and aluminum powder as pore-forming agents in lightweight geopolymer synthesis
  156. Synthesis of high surface area mesoporous silica SBA-15 by adjusting hydrothermal treatment time and the amount of polyvinyl alcohol
  157. Review of large-pore mesostructured cellular foam (MCF) silica and its applications
  158. Ion Exchange of Benzoate in Ni-Al-Benzoate Layered Double Hydroxide by Amoxicillin
  159. Synthesis And Characterization Of CoMo/Mordenite Catalyst For Hydrotreatment Of Lignin Compound Models
  160. Production of Biodiesel from Nyamplung (Calophyllum inophyllum L.) using Microwave with CaO Catalyst from Eggshell Waste: Optimization of Transesterification Process Parameters
  161. The Study of the Optical Properties of C60 Fullerene in Different Organic Solvents
  162. Composite Material Consisting of HKUST-1 and Indonesian Activated Natural Zeolite and its Application in CO2 Capture
  163. Topical Issue on Environmental Chemistry
  164. Ionic liquids modified cobalt/ZSM-5 as a highly efficient catalyst for enhancing the selectivity towards KA oil in the aerobic oxidation of cyclohexane
  165. Application of Thermal Resistant Gemini Surfactants in Highly Thixotropic Water-in-oil Drilling Fluid System
  166. Screening Study on Rheological Behavior and Phase Transition Point of Polymer-containing Fluids produced under the Oil Freezing Point Temperature
  167. The Chemical Softening Effect and Mechanism of Low Rank Coal Soaked in Alkaline Solution
  168. The Influence Of NO/O2 On The NOx Storage Properties Over A Pt-Ba-Ce/γ-Al2O3 Catalyst
  169. Special Issue on the International conference CosCI 2018
  170. Design of SiO2/TiO2 that Synergistically Increases The Hydrophobicity of Methyltrimethoxysilane Coated Glass
  171. Antidiabetes and Antioxidant agents from Clausena excavata root as medicinal plant of Myanmar
  172. Development of a Gold Immunochromatographic Assay Method Using Candida Biofilm Antigen as a Bioreceptor for Candidiasis in Rats
  173. Special Issue on Applied Biochemistry and Biotechnology 2019
  174. Adsorption of copper ions on Magnolia officinalis residues after solid-phase fermentation with Phanerochaete chrysosporium
  175. Erratum
  176. Erratum to: Sand Dune Characterization For Preparing Metallurgical Grade Silicon
Downloaded on 18.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2019-0092/html?srsltid=AfmBOooopvHggitfvLbUhGT-Yi76jynQvjY7PbFfiGa-d6gSUSAgqt7H
Scroll to top button